Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Risk Management

Risk Management

Caroline Daelemans, Professor

ULB
"Our objectives are: • To study maternal and neonate COVID-19 information in the Belgian-Obstetric Surveillance System database: clinical presentation and natural history of disease, pregnancy-related basic information, pregnancy outcomes, birth characteristics, infant morbidity and mortality. • To study the core socio-demographic information to potentially identify groups at higher risk of complications • Build a more informative dataset thanks to data mining of public databases This study will enable us to understand the impact of COVID-19 on pregnant women and their offspring in Belgium, and in the world via the contribution to the INOSS multicenter study. It might allow us to define an at-risk population among pregnant women and their offspring, and tailor epidemiologic and clinical interventions for these more vulnerable individuals."
Funding: Pending (FNRS)
Publication References: "1. The International Network of Obstetric Survey Systems study of uterine rupture: a...

Eric Haubruge, Professeur ordinaire

ULiège
" Development of Methods for Mask and N95 Decontamination (the DeMaND study) and reuse for healthcare workers at the frontline The aim of this study is to identify and test, simple low-cost safe decontamination methods to enable medical masks and N95/ FFP2 respirators reuse in healthcare settings where there are critical shortages. "
Funding: Open Philanthropy
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it. 

Eric Haubruge, Professeur ordinaire - Etienne Thiry, Professeur ordinaire - Georges Daube, Professeur ordinaire

ULiège
"DECONTAMINATION AND REUSE OF SURGICAL MASKS AND FILTERING FACEPIECE RESPIRATORS The global test protocol, presented in this project, aims to assess: a) the effectiveness of several decontamination methods with regard to integrity (""barrier"" function) and the quality of surgical masks and filtering facepiece respirators FFP2/N95; b) the efficacy of these decontamination methods on the inactivation of a coronavirus, similar to the SARS-CoV-2 virus present on surgical masks and filtering facepiece respirators FFP2/N95. Moreover, the present project aims to set up a consortium of companies and laboratories to meet the diverse and varied requests for ""reuse"" of various medical protective equipment (masks, filters, clothing, etc.) linked with the environmental approach."
Funding: Walloon Government
Contact: https://www.news.uliege.be/cms/c_11717821/fr/l-uliege-coordonne-le-projet-wallon-de-decontamination-des-masques-chirurgicaux-et-de-protection-respiratoire-ffp2...

Glenn Magerman, Professor - Mathias Dewatripont, Professor - Bram De Rock, Professor

ULB
" Learning from the curve is a voluntary and open source research project on COVID-19 and economics. It is a joint initiative of researchers in economics at ECARES, Solvay, ULB. Our mission is to provide detailed and real-time information and visualizations on COVID-19 and economics for the general public and the press, to serve as a platform for research collaboration on these topics, to understand the impact of COVID-19 on the economic tissue of countries and regions, to provide policy recommendations based on scientific arguments supported by data analytics. Learning from the curve started as a voluntary effort of faculty and students in empirical economics at ECARES. We are also very grateful for funding from the Special COVID-19 ULB grant. None of this would be possible without either. We call data from various sources, which are referenced in the respective dashboards and articles. We provide data sources and code on our Github organization. All publicly available data, code...

Gregory Ponthiere, Professor

UCLouvain
" This research project aims at studying the conditions under which the modern welfare state could build a kind of epidemics insurance, while paying a particular attention to the issue of fairness. The global objective of saving lives may be associated to policies that have undesirable distributive effects, against ideals of social justice. The project aims at finding ways to make mass prevention and equity compatible. "
Funding: This project will be part of my research load at UCLouvain, within the Hoover Chair in Economic ans Social Ethics.
Publication References: Fleurbaey, M., Ponthiere, G. (2013). Prevention against Equality ? Journal of Public Economics. Fleurbaey, M., Leroux, ML, Ponthiere, G. (2014). Compensating the dead. Journal of Mathematical Economics. Fleurbaey, M., Leroux, ML., Pestieau, P., Ponthiere G. (2016). Fair retirement under risk lifetime. International Economic Review. Leroux, ML., Ponthiere, G. (2018). Working time regulations, unequal lifetime and...

Jean-Paul Deslypere, MD

Aesculape CRO Belgium BV
" Treatment of COVID 19 complications with antibodies "
Funding: partly public partly private
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it. 0492 735931

Martin Erpicum, CEO of Mesydel and researcher

ULiège + Mesylab SRL
" How to securely return to normalcy at work? All countries consider to lift the lockdown, but few have executed it. There are no "best practices". Questions abound: What are the risks? What are the most effective measures? Will communities follow? What are the consequences for our individual lives? Who decides how to proceed? AIMS OF THE PROJECT GIGA aims at defining the best possible approach to opening up again by involving its members. Your opinion matters. GIGA has sought assistance in conducting this real time experiment from political scientists, philosophers, lawyers and medical doctors. "
Contact: This project is supported by the GIGA office and is coordinated by the ad hoc Advisory Committee made up of expert political scientists in participation (Dr. F. Thoreau, Dr. C. Parotte, Dr. P. Delvenne, Dr. C. Fallon), a political and ethicist philosopher (Dr. F. Caeymaex) and doctors (Dr. Y. Beguin, Dr. G. Darcis).

Mona Momeni, MD, PhD

UCLouvain/Cliniques universitaires Saint-Luc 
" COVID-19 pandemic has an important impact on the health care provided by the anesthesiologists. Different societies of anesthesiology have provided guidelines and recommendations on how to manage patients who have been tested positive for COVID-19 or suspected to be infected. It is therefore important to know whether these guidelines have been implemented or were possible to be implemented. Otherwise patients who are presenting COVID-19 often show pulmonary complications. The airway management and the ventilation management of these patients can be therefore challenging and can possibly influence their outcome. It is thus important to obtain a large database with information about the characteristics of these patients, how these patients have been managed and their in-hospital outcome. Information regarding the correct implementation of guidelines is as well necessary for future guidance of health care providers. "
Funding: None
Contact...

Wim Laurier, Chargé de cours

USL-B 
" The pharmaceutical industry is confronted with many different issues at the levels of logistics and supply chain management. Traceability is a paramount in the pharmaceutical sector. It is not only essential to ensure the quality of the product, but also, it is required to trace possible adverse reactions back to a given lot of drug product, its manufacturing and control. Traceability needs to be addressed at three stages. First, the source (supplier) and origin (e.g. chemical, microbiological, animal, human…) of raw and starting materials must be identified. These materials must be tested and found compliant with compendial requirements. Second, traceability must be ensured in-house, throughout the all manufacturing process, from starting materials to the drug product, through the drug substance and all intermediates. Third, traceability should be ensured downstream, from lot release by the company to patient's administration. Traceability within the industry (stage 2) is...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19